Full-Time

Medical Science Liaison

Rare Diseases

Confirmed live in the last 24 hours

Takeda

Takeda

10,001+ employees

Global biopharmaceutical firm focused on R&D

No salary listed

Mid, Senior

British Columbia, Canada

Candidates must be based in British Columbia.

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Requirements
  • MD, Ph.D. or Pharm.D.
  • BSc/MSc. + years’ experience may be considered depending on past relevant pharmaceutical industry experience, and/or clinical work, research, or academic endeavors.
  • A solid scientific background with a thorough understanding of the pharmaceutical industry and an established strong ability to think strategically and critically.
  • Well-versed in highly technical and scientific languages to communicate with key Thought Leaders, Medical Affairs, Research and Development, Marketing, as well as other key internal and external stakeholders.
  • Firm understanding of the key phases, processes, and techniques that are involved in both the pre-clinical and clinical aspects of drug development.
  • Understanding of the Canadian healthcare infrastructure, particularly the role of academic teaching and research institutes within this.
  • Understanding of physiology, pharmacology, and biostatistics at a level sufficient to allow meaningful dialogue with regional opinion leaders.
  • Legislation (e.g. Food and Drug Act), IMC code, Rx&D Code of Conduct, Clinical Practice Guidelines, general functions of TPD and provincial formularies, competitor activities, key customer groups, advocacy groups, general market dynamics.
  • Strong pharmaceutical business acumen
  • Proficiency in Microsoft Office applications and other systems (e.g. Veeva/SMILE, CRM).
  • Proven track record of teamwork, leadership, timely decision making and results orientation in meeting objectives and deliverables.
  • Demonstrated orientation towards being self-motivated and self-directed. Possesses excellent communication skills, both oral and written, and able to engender trust and respect of peers, subordinates and superiors based on strong interpersonal skills.
  • Is able to influence without authority. Proven experience in building relationships with key decision-makers. Excellent skills in presenting clear, accurate and persuasive presentations.
Responsibilities
  • Establish Takeda’s presence with thought leaders and academic institutions in Western Canada (BC, AB, SK) for therapeutic areas within Takeda’s Rare Diseases Business Unit.
  • Provide medical insights, intelligence and recommendations from the field to support the development and life-cycle management of Takeda compounds.
  • Provide medical and scientific expertise to commercial partners as needed and within regulatory guidelines.
  • In assigned therapeutic area(s), identify and develop relationships with key thought leaders that are in alignment with Takeda Canada’s scientific and business objectives.
  • Provide scientific expertise and engage in ongoing scientific exchange and balanced discussion of science, to support the assigned region with product and disease state knowledge through individual and group presentations of scientific information to both key thought leaders and to internal Takeda personnel, and between these groups.
  • Ensure Medical Scientific Liaison (MSL) metrics (both quantitative and qualitative) are achieved.
  • Collect medical insights and intelligence and interpret and communicate relevant information in order to define, update, and support the organization’s scientific and business strategies as it relates to the brand(s), competitors, disease states and overall therapeutic knowledge.
  • Identify educational opportunities that are aligned with Takeda’s medical education strategies.
  • Provide assistance with clinical education, publication, communication, training, and advisory programs, to support key thought leader and/or company initiatives.
  • Identify and facilitate Investigator Sponsored Research (ISR) aligned with Takeda’s medical strategies. Facilitate review and track progress of ISR proposals.
  • Provide assistance in identifying, evaluating, and screening qualified research sites for clinical investigation.
  • Provide medical booth and session coverage at scientific meetings and reports information of strategic interest to Takeda, along with scientific representation of company at scientific meetings.
  • Address unsolicited requests for medical information from health care professionals, including physicians, patient advocacy groups, medical institutions, pharmacy, etc.
  • Deliver scientific and medical training to internal partners.
  • Provide clinical presentations and medical information to government accounts, upon request.
  • Complete all required training, activity documentation, expense reporting, and other administrative responsibilities in a timely and accurate manner.
  • Perform all company business in full compliance with all regulations (e.g., IMC, Health Canada, Rx&D, PAAB, etc.), company policies and procedures, and industry or legal requirements.
  • Reporting of Adverse Events (AEs) Adverse Drug Reactions (ADRs) and Product Quality Complaints (PQCs)
Desired Qualifications
  • Minimum 2 years of medical liaison experience within the pharmaceutical industry, with 5 years of healthcare or experience in one or more of the following (medical affairs, managed markets, clinical practice, clinical research or academic) following award of health sciences degree.
  • Therapeutic area experience in Rare Diseases is an asset.
  • Clinical, research, or teaching experience.

Takeda Pharmaceutical Company Limited is a global biopharmaceutical firm that focuses on developing and delivering treatments and vaccines. The company invests heavily in research and development to create new molecular entities (NMEs) and has a pipeline of 11 NMEs, aiming for up to 15 product launches by FY2024. Takeda's products are designed to meet the needs of healthcare providers, hospitals, and patients around the world. What sets Takeda apart from its competitors is its strong commitment to patient-centric values and environmental sustainability, recognizing the connection between human health and environmental health. The company's goal is to innovate and provide life-changing therapies while ensuring that patient needs are prioritized.

Company Size

10,001+

Company Stage

IPO

Headquarters

Tokyo, Japan

Founded

1781

Simplify Jobs

Simplify's Take

What believers are saying

  • Takeda's focus on personalized medicine can increase treatment efficacy and patient satisfaction.
  • Expansion in Southeast Asia offers opportunities for increased market presence and revenue growth.
  • Collaborations with tech companies can accelerate R&D processes and reduce costs.

What critics are saying

  • Data breach could lead to financial and reputational damage for Takeda.
  • Antitrust litigation with Meijer may result in financial penalties or business practice changes.
  • High financial commitments in partnerships could strain resources if outcomes are not achieved.

What makes Takeda unique

  • Takeda has a 240-year history in the biopharmaceutical industry.
  • The company emphasizes patient-centric values in its operations and R&D efforts.
  • Takeda's robust pipeline includes 11 NMEs with plans for 15 product launches by FY2024.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Wellness Program

Tuition Reimbursement

Company News

CyberNews
Apr 15th, 2025
Hackers want $75,000 for data allegedly stolen from Takeda

A new account on an illicit forum bearing the moniker "beltway" claims that in April 2025, it exported around two million rows of user information from Takeda.com.

MLex
Mar 4th, 2025
Meijer seeks quick appeal in US antitrust case against Takeda

( March 4, 2025, 17:06 GMT | Official Statement) - MLex Summary: Meijer asked a US federal judge for leave to immediately appeal an order that sent its antitrust case against Takeda Pharmaceuticals over the drug Amitiza to arbitration.

BioSpace
Mar 3rd, 2025
Takeda-Protagonist Drug for Incurable Cancer Reduces Need for Blood Withdrawals in Phase III Trial

Protagonist, which will receive a $25 million milestone from Takeda thanks to the positive results, plans to submit the findings to regulators.

Access Health
Mar 3rd, 2025
Strengthening Access to Medicines in Southeast Asia: Highlights from Southeast Asia Access to Medicine (SEA AtM) Summit

ACCESS Health International, in collaboration with AVPN, SingHealth Duke-NUS Global Health Institute, and Takeda, successfully co-hosted the first Southeast Asia Access to Medicine (SEA AtM) Summit in Bangkok.

Pharmaceutical Technology
Feb 25th, 2025
Takeda broadens its deal with BridGene for up to $770m

Bridgene and Takeda have inked a deal worth $770m to develop small molecules for immunology and neurology.